High DCR and Better Survival in Patients with Advanced or Metastatic Gastric Cancer Receiving Anti-Angiogenic TKI plus Chemotherapy: A Real-World Study

Objectives: This study was carried out to assess the efficacy and drug toxicity of anti-angiogenic tyrosine kinase inhibitor (TKI) plus chemotherapy as second-line or above therapeutic regime in advanced or metastatic gastric cancer patients. Methods: From November 2017 to April 2020, advanced or me...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Caiyun, Lv, Huifang, Chen, Beibei, Xu, Weifeng, Wang, Jianzheng, Wang, Saiqi, Liu, Yingjun, He, Yunduan, Zhao, Jing, Chen, Xiaobing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982383/
https://www.ncbi.nlm.nih.gov/pubmed/36632666
http://dx.doi.org/10.1177/15330338221150561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982383/
https://www.ncbi.nlm.nih.gov/pubmed/36632666
http://dx.doi.org/10.1177/15330338221150561

Ejemplares similares